Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Hannah Peckham(Arthritis UK), Nina M. de Gruijter(Arthritis UK), Charles Raine(British Society for Rheumatology), Anna Radziszewska(Arthritis UK), Coziana Ciurtin(Arthritis UK), Lucy R. Wedderburn(Great Ormond Street Hospital), Elizabeth C. Rosser(Arthritis UK), Kate Webb(University of Cape Town), Claire T. Deakin(Great Ormond Street Hospital)
Nature Communications
December 9, 2020
Cited by 1,574Open Access
Full Text

Abstract

Anecdotal evidence suggests that Coronavirus disease 2019 (COVID-19), caused by the coronavirus SARS-CoV-2, exhibits differences in morbidity and mortality between sexes. Here, we present a meta-analysis of 3,111,714 reported global cases to demonstrate that, whilst there is no difference in the proportion of males and females with confirmed COVID-19, male patients have almost three times the odds of requiring intensive treatment unit (ITU) admission (OR = 2.84; 95% CI = 2.06, 3.92) and higher odds of death (OR = 1.39; 95% CI = 1.31, 1.47) compared to females. With few exceptions, the sex bias observed in COVID-19 is a worldwide phenomenon. An appreciation of how sex is influencing COVID-19 outcomes will have important implications for clinical management and mitigation strategies for this disease.


Related Papers

No related papers found

Powered by citation graph analysis